[The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?].
The use of the GnRH antagonists during ovarian stimulation for intrauterine insemination is relatively recent. The primary aim was to improve the timing of the inseminations on working days. However, according to published data, the consequences on pregnancy rate remain uncertain. Moreover, the impact of this strategy on stimulation's parameters, specifically on the size of the follicle cohort, should be better assessed.
Pasquier
M
M
Service de médecine de la reproduction, université Paris-XIII, CHU Jean-Verdier, avenue du 14-Juillet, 93140 Bondy, France. maud.pasquier@gmail.com
Maitrot
L
L
Leperlier
F
F
Dehghani
C
C
Snaifer
E
E
Durnerin
I-C
IC
Hugues
J-N
JN
D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D007246:Infertility / Q000188:drug therapy / Q000628:therapy*; D007315:Insemination, Artificial; D007986:Luteinizing Hormone / Q000097:blood*; D016471:Ovarian Hyperstimulation Syndrome / Q000517:prevention & control; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D018873:Pregnancy Rate
D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone